ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

In Brief: Grand Jury To Consider Charges Against N.M. Community Based Cancer Program Staff Members

January 4, 1980

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt

November 17, 1978

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013